The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Helix Biopharma Corp closed at $0.84.

Over the last five days, shares have gained 2.44%, but are down 45.45% for the last year to date. Shares have underperformed the S&P TSX by 55.54% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated at previous session's close. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedJul 31, 201707/31/2017Apr 30, 201704/30/2017Jan 31, 201701/31/2017Oct 31, 201610/31/2016
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense1333
Selling / general / administrative0111
Research & development1222
Depreciation / amortization----00
Interest expense (income), net operating--------
Unusual expense (income)000--
Other operating expenses, total--------
Operating income-1-3-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-1-3-3-3
Income after tax-1-3-3-3
Income tax, total--------
Net income-1-3-3-3
Total adjustments to net income--------
Net income before extra. items-1-3-3-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-3-3-3
Inc. avail. to common incl. extra. items-1-3-3-3
Diluted net income-1-3-3-3
Dilution adjustment--------
Diluted weighted average shares95929189
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.03-0.03-0.04
Dividends per sharevalue per share--
Diluted normalized EPSvalue per share-0.01-0.03-0.03-0.04